The abstract is read at the publisher; the summary is JClub's.
Prophylactic targeted muscle reinnervation (TMR) or regenerative peripheral nerve interface (RPNI) at limb amputation is linked to lower phantom limb pain incidence and intensity (PLP RR 0.56; g = -0.68).
- Why it matters: Phantom limb pain and residual limb pain after amputation can hinder rehabilitation, prosthetic use, and quality of life, and evidence is needed on whether prophylactic nerve-targeting reduces chronic pain.
- What they did: A PRISMA 2020 systematic review and meta-analysis of 27 studies (30 records, 2,154 participants) pooled pain intensity (Hedges’ g) and incidence (risk ratios) for PLP and RLP using random-effects DerSimonian-Laird models.
- The result: Compared with standard nerve management in comparative analyses, TMR/RPNI was associated with lower PLP (RR 0.56, 0.48–0.65; g = -0.68, -0.82 to -0.55) and lower RLP (RR 0.55, 0.42–0.73; g = -0.68, -0.95 to -0.40), with low-to-very-low certainty and no clear safety differences.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.